Judge Denies Centocor's Motions for Summary Judgment, Exclude Expert

ST. LOUIS, Mo. - Remicade manufacturer Centocor's motion for summary judgment was denied April 15 by a federal judge, who ruled that there were genuine issues of material fact that precluded granting the motion. Rolwes v. Centocor, Inc., et al. No. 03-CV-151 (E.D. Mo.).

U.S. District Judge Charles A. Shaw also denied the company's motion in limine to exclude the opinions of plaintiff's expert Dr. Donald Marks, finding that his opinions satisfied the standards established under Daubert.

Summary Judgment

Centocor and its parent company Johnson & Johnson moved for summary judgment Feb. 17 on the ground that Janet Rolwes …